Navigation Links
President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
Date:9/14/2007

the United States on the world stage."

Leadership through experience

In addition to her role as the founder of Komen for the Cure, Ambassador Brinker, a breast cancer survivor and sister to Susan G. Komen, served as U.S. Ambassador to the Republic of Hungary and has served on the National Cancer Panel under Presidents Reagan and Bush. She has been an advocate in congressional hearings, the U.S. Democratic Policy Committee's Congressional Breast Cancer Forum and the National Dialogue on Cancer, now known as C-Change.

"The role of Chief of Protocol is exceptionally fitting for Nancy G. Brinker, the founder of Susan G. Komen for the Cure, which started the global breast cancer movement, and is a leader in global health diplomacy," said Hala Moddelmog, president and CEO of Susan G. Komen for the Cure. "She represents the great American story of strength and courage - one woman who has changed the lives of millions around the world. Because of her life work, Ambassador Brinker has an extraordinary ability to relate to people at all levels, which is ideal for this service role."

Increasing awareness on a global level

Working through Komen, Ambassador Brinker has fostered understanding of women's health issues, particularly breast cancer, to transcend barriers and improve the lives of women everywhere. From delivering life-saving messages to people in more than 200 countries, to providing funds to programs in 50 countries, to creating a dialogue in places where it is still not possible to say the words "breast cancer" out loud, Komen for the Cure has demonstrated how local activism drives global social change.

Today, Susan G. Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists and the largest private source of funds for breast cancer research and community outreach programs. As it has for the past 25 years, Susan G. Komen for the Cure and its millions of supporters will remain steadfast i
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Clintons new problem - Is the outgoing American president suffering from skin cancer?
2. Past President Narayanans Condition Still Critical
3. President and Founder of National Obesity Forum Resigns
4. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
5. President Bush proposes HSAs scheme for the benefit of both the workers and the country
6. President’s verdict: no need to panic over bird fl
7. Delhi Hospitals On Standby For President Bush
8. Former IMO President Shows Interest In Winning General Election
9. Chicken Dishes Were Off The Menu At Pakistan Presidents House
10. Man Appeals to President to Save His Ailing Son
11. President Kalam Meets Striking Medicos However Stir to Continue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)... are being urged to think before they drink as par...binge drinking habits. , A team of health psycho...scover whether using the workplace to supply infor... asking employees for a small commitment to reduci... change peoples binge drinking behaviour in the lo...
(Date:5/12/2008)...ted gene has been discovered as the key behind epi...anks to new research at Adelaides Womens & Childre...lia. , The world-first discovery, published toda...y the bad gene, only women are affected. , The r...ciate Professor Jozef Gecz from the Department of ...
(Date:5/12/2008)...OUTH MEETING, Pa., May 12 /Xinhua-PRNewswire-First...,BMP Sunstone, or the ,Company,),one of China,...l companies,today announced that it plans to rele..., May 19, 2008, before the market opens., The Com...:00 am ET to,discuss fiscal first quarter 2008 res...
(Date:5/12/2008)...I PROVINCE, China, May 12 /Xinhua-PRNewswire-First...Board: BPMA), a China-based,pharmaceutical company...e,therapy medicine for the treatment of cancer, an...today announced that it has appointed Jun Tang to,...r. Tang has over a decade of experience in corpora...
Breaking Medicine News(10 mins):Health News:Think before you drink, says university research 2Health News:Mutant gene causes epilepsy, intellectual disability in women 2Health News:BMP Sunstone to Report First Quarter 2008 Financial Results 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 3
...a reports on dubious medical stories can harm the ...in the British Medical Journal//. Media reporting ...ated with a fall in donations for ethically approv...ds a study in latest BMJ. This analysis shows how ...
...5. A researcher in New Zealand has developed a de... suffer from sleep apnoea, where breathing stops d...of problems from high blood pressure and diabetes ...on the strife and misery caused by snoring partner...
...s not discriminate between rich and poor, if not d...s have succumbed to it and some have fought it and...actresses and personalities who have suffered from...n -Actress and SingerShirley Temple Black - Actres...
...Cedars-Sinai Medical Center had developed a device...o detect the inflammation that is //part of plaque...w, in a study involving laboratory rabbits, a devi...res light emissions from body tissues has been abl...
Other Medicine News:Health News:A Cheap Device to Stop Snoring from New Zealand 2Health News:Researchers Develop Device For Detecting Atherosclerotic Plaques 2
(Date:5/9/2008)...wswire/ -- The risk of the two major,prostate dise...), can be,reduced by changes in lifestyle, such as... eating a healthy diet. Alan Kristal, Dr.P.H., ass...ed Hutchinson Cancer Research,Center in Seattle, h...t,feel helpless against prostate cancer or BPH.,...
(Date:5/8/2008)...rstCall/ -- DATATRAK International, Inc.,(Nasdaq: ... on global,eClinical solutions for the clinical tr...s for the first quarter of 2008., For the three m...oximately 41% to $2,088,000 and the Company report...e on both a basic and diluted basis. These,results...
(Date:5/8/2008)...FirstCall/ -- Alpharma Inc. (NYSE: ALO ),a globa...d results from,clinical trials that showed ALO-01 ...th sequestered naltrexone hydrochloride) capsules,...ng abuse liability,alongside a promising safety an...esented at the 27th Annual Scientific Session of t...
(Date:5/8/2008)...s on Use of Pro-Healing Stent with AMI Patients...herapy, HONG KONG, May 8 /- Twelve-m...tudy and the real-world registry use of OrbusNeich...t pro-healing stent, will be,presented next week i..., The symposium, titled "Clinical Impact of the P...
Breaking Medicine Technology:Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2Cells united against cancer 161 1Cells united against cancer 161 2Giving CPR Kits to Kids Nudges Parents to Learn 206 1Giving CPR Kits to Kids Nudges Parents to Learn 206 2Scientists identify embryonic stem cells by appearance alone 158 1Scientists identify embryonic stem cells by appearance alone 158 2Scientists identify embryonic stem cells by appearance alone 158 3Obesity Rate in U S Still Climbing 201 1Obesity Rate in U S Still Climbing 201 2Obesity Rate in U S Still Climbing 201 3Obesity Rate in U S Still Climbing 201 4
...stCall/ -- Vanda,Pharmaceuticals Inc. announced to...Sleep Disorders and Research Center in Detroit, MI...e III clinical,trial results for VEC-162, Vanda,s ...SLEEP 2007, the 21st annual meeting of the,Associa...nda presentation will take place at the Convention...
...tion during the,early post-operative period compar...tion in nausea in the female,patient population co...- CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambri...itional data from post-hoc analysis of the recent ...onide) in over 500 patients,with post-operative pa...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: